Is Aspen a good buy?
Aspen, with a market cap of around $10bn, is the largest pharmaceutical company listed on the JSE. Come and listen to our equity analyst Bianca Haywood explain why we recommend portfolio exposure of up to 2.57% of this share.
Click here to download the presentation slides as a PDF.
Presented by equity analyst, Bianca Haywood.